VSee Health, Inc. (VSEEW) company profile
Close on Oct 9, 2026Market cap $965.84KP/E –Yield –
About VSee Health
Services-Health Services, SIC 8000
VSee Health, Inc. provides digital healthcare and telehealth technology solutions designed to facilitate patient engagement, clinical coordination, and critical care delivery. Through its subsidiary VSee Lab, the company offers a modular, no-code and low-code telehealth software platform featuring tools for virtual patient visits, appointment scheduling, intake management, remote medical examinations, and remote patient monitoring. Through its subsidiary iDoc, the company delivers specialized tele-intensive care and virtual specialist staffing services, including neurocritical, cardiac, and pulmonary critical care coverage, as well as electronic consultations across numerous medical specialties. Its primary customers include health systems, large and small hospitals, long-term acute care facilities, and the Federal Bureau of Prisons.
The company operates primarily within the United States, serving diverse healthcare enterprises ranging from academic medical centers to micro-hospitals and federal correctional facilities. VSee Health maintains its principal executive offices in Boca Raton, Florida.
Summary of the business section of VSee Health's latest annual report, written by StockData.
Company profile
Company
- Legal name
- VSee Health, Inc.
- Headquarters
- Boca Raton, FL
- Address
- 980 N Federal Hwy, #304 33432
- Phone
- (561) 672-7068
- Website
- vseehealth.com
- Employees
- 209, Dec 31, 2025
- Industry
- Services-Health Services
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- WWC, P.C., San Mateo, California
Stock & identifiers
- Ticker
- VSEEW
- Other tickers
- VSEE, VSEED
- Exchange
- OTC
- IPO date
- Nov 4, 2021
- Shares outstanding
- 57M, Aug 12, 2026
- Public float
- $18.17M, Jun 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Stock splits
- 1-for-80 reverse, Sep 24, 2026
- SEC CIK
- 1864531
- CUSIP
- 92919Y110
- ISIN
- US92919Y1102
- FIGI
- BBG0149QDRN4
- EIN
- 86-2970927
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Milton Chen | Co-Chief Executive Officer, Director | 0 |
| Imoigele Aisiku | Co-Chief Executive Officer, Director | 3,338,000 |
| Jerry Leonard | Chief Financial Officer | 603,109 |
| Scott Metzger | Director | 117,356 |
| Colin P. O'Sullivan | Director | 108,731 |
| David L. Wickersham | Director | 2,335,235 |
| Kevin Lowdermilk | Director | 108,731 |
| Cydonii V. Fairfax | Director | 108,504 |
Executive compensation, fiscal 2025
Summary compensation table from the latest proxy statement
| Executive | Salary | Bonus | Stock awards | Total | vs. prior year |
|---|---|---|---|---|---|
| Imoigele P. Aisiku Chief Executive Officer and Chairman | $200.00K | $192.00K | $192.00K | $584.00K | +172% |
| Milton Chen Former Co- Chief Executive Officer and Chairman (2) | $200.00K | $100.00K | – | $300.00K | +150% |
| Jerry Leonard Senior Vice President, and Chief Financial Officer | $250.00K | $200.00K | $258.95K | $708.95K | +184% |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
IPO
From the final prospectus (Form 424B4) and the first day of trading
SPAC offering
- Type
- SPAC (blank check) IPO of units
- Final prospectus filed
- Nov 4, 2021
- Offer price
- $10.00
- Securities offered
- 10,000,000
- Gross proceeds
- $100.00M
- Exchange
- Nasdaq
- First trading day
- Dec 31, 2021
- First-day close
- $9.88-1.2%
- Lock-up ends (est.)
- Jun 29, 2022
“We are offering 10,000,000 units at an offering price of $10.00 per unit.”
Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.
Employees
Headcount reported in annual reports
“We currently have approximately 209 full-time equivalent employees and contractors, of which approximately 93 are board certified practicing physicians.”
Corporate history
Events identified from SEC filings